Humana Inc. (HUM) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	145.7B	129.7B	117.8B	106.4B	92.9B
Cost of Revenue	125.8B	110.8B	100.7B	88.4B	75.7B
Gross Profit	19.9B	18.9B	17.1B	18.0B	17.2B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	4.0B	—	—	—	—
General & Admin Expense	4.0B	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	13.9B	17.4B	15.5B	14.7B	13.7B
Total Operating Expenses	17.9B	17.4B	15.5B	14.7B	13.7B
Cost and Expenses	143.7B	128.2B	116.2B	103.1B	89.4B
Operating Income (EBIT)	2.0B	1.5B	1.6B	3.3B	3.6B
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	704.0M	631.0M	660.0M	493.0M	401.0M
Net Interest Income	(704.0M)	(631.0M)	(660.0M)	(493.0M)	(401.0M)
Other Non-Op Income/Expense	(408.0M)	—	—	—	—
Non-Operating Income (excl Interest)	(296.0M)	(631.0M)	(660.0M)	(493.0M)	(401.0M)
EBT (Pre-Tax Income)	1.6B	1.5B	1.6B	3.3B	3.6B
Income Tax Expense	298.0M	250.0M	413.0M	836.0M	762.0M
Bottom Line
Net Income	1.3B	1.2B	1.2B	2.5B	2.8B
Earnings from Cont. Ops	1.3B	1.2B	1.2B	2.5B	2.8B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	1.3B	1.2B	1.2B	2.5B	2.8B
Per Share
Basic EPS	$10.65	$9.87	$10.01	$20.09	$22.20
Diluted EPS	$10.56	$9.84	$9.98	$20.00	$22.08
Revenue Per Share	$1,211.98	$1,076.46	$977.11	$859.32	$735.03
Shares
Basic Shares Outstanding	120.2M	120.5M	120.6M	123.9M	126.4M
Diluted Shares Outstanding	120.9M	120.8M	120.9M	124.4M	127.1M
Profitability Metrics
EBITDA	3.1B	2.9B	3.3B	4.7B	4.8B
D&A	751.0M	824.0M	968.0M	917.0M	845.0M
EBIT	2.3B	2.1B	2.3B	3.8B	4.0B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026